阿西拉制药公司
US ˙ NasdaqCM ˙ US04746L1044

介绍

本页面提供了有关 Mark James Litton 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言,基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是,他们必须通过Form 4向美国证券交易委员会(SEC)报告所有交易。尽管存在这些限制,学术研究表明,整体而言,内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易,排除了作为10b5-1交易计划的一部分的交易。然后,对每笔交易在3、6和12个月的表现进行平均,以生成该笔交易最终的表现指标。然后,将所有交易的表现指标进行平均,计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A",则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易,或者他们进行的交易距离现在时间太近,无法计算出可靠的表现指标。

更新频率:每日

查看收益最高的的内幕交易者列表。

报告内部持仓的公司

美国证券交易委员会(SEC)文件显示Mark James Litton已报告在以下公司拥有持仓或进行了交易:

证券 职位 最新报告的持仓
US:ATHA / Athira Pharma, Inc. President and CEO, Director 325,802
US:ALPN / Alpine Immune Sciences, Inc. See Remarks 75,000
US:ALDR / Alder BioPharmaceuticals, Inc. Chief Business Officer 0
如何解读这些图表

以下图表显示了在Mark James Litton进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如,如果一笔内部人士交易是在2019年1月1日进行的,该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元,则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%,而从10美元跌至5美元的价格变化将为-50%。

最终,我们将评估内部人士的交易与股价的超额回报(正向或负向)之间的相关性,以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为,我们预期看到(a)买入后的正回报,或者(b)卖出后的负回报。对于情况(a),买入图表将显示一系列向上倾斜的曲线,表示每次买入后都有正回报。对于情况(b),卖出图表将显示一系列向下倾斜的曲线,表示每次卖出后都有负回报。

然而,仅凭这一点还不足以得出结论。例如,如果公司的股价在多年内呈现非周期性上升,我们会预期所有买入后的图表都呈现向上倾斜。同样地,多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下,“买入”图表显示正向信号,而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易,以获得财务优势。

ATHA / Athira Pharma, Inc.内部人士买入 - 短期收益分析

在这一部分,我们分析了在 ATHA / Athira Pharma, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报,以及是否值得跟踪。该分析基于每笔交易后一年的情况,结果仅为理论值

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最高利润的
天数
达到最高利润时的
价格
最高
利润($)
最高回报率(%)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ATHA / Athira Pharma, Inc. Insider Trades
ATHA / Athira Pharma, Inc.内部人士卖出 - 短期亏损分析

在这一部分,我们分析了在 ATHA / Athira Pharma, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式,可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况,

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最低利润的
天数
达到最低利润时的
价格
避免的
最高损失金额($)
避免的
最高损失率($)
2025-07-01 ATHA Litton Mark James 25,123 0.2935 25,123 0.2935 7,374 0 0.3000 164 2.22
2025-01-02 ATHA Litton Mark James 25,107 0.5619 25,107 0.5619 14,108
2024-09-05 ATHA Litton Mark James 5,032 0.5660 5,032 0.5660 2,848
2024-01-05 ATHA Litton Mark James 4,820 2.9100 4,820 2.9100 14,026
2024-01-05 ATHA Litton Mark James 4,820 2.9100 4,820 2.9100 14,026
2022-06-23 ATHA Litton Mark James 7,960 2.6900 7,960 2.6900 21,412

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ATHA / Athira Pharma, Inc. Insider Trades
内幕交易历史

该表格显示了由 Mark James Litton 进行的所有内幕交易的完整列表,这些交易已向美国证券交易委员会(SEC)披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化
每股
股价
交易
金额
剩余
金额
2025-07-02 2025-07-01 4 ATHA Athira Pharma, Inc.
Common Stock
S - Sale -25,123 325,802 -7.16 0.29 -7,374 95,623
2025-07-02 2025-06-30 4 ATHA Athira Pharma, Inc.
Common Stock
M - Exercise 108,334 350,925 44.66
2025-01-03 2025-01-02 4 ATHA Athira Pharma, Inc.
Common Stock
S - Sale -25,107 242,591 -9.38 0.56 -14,108 136,312
2025-01-03 2024-12-31 4 ATHA Athira Pharma, Inc.
Common Stock
M - Exercise 108,333 267,698 67.98
2024-09-05 2024-09-05 4 ATHA Athira Pharma, Inc.
Common Stock
S - Sale -5,032 159,365 -3.06 0.57 -2,848 90,201
2024-09-05 2024-09-03 4 ATHA Athira Pharma, Inc.
Common Stock
A - Award 20,000 164,397 13.85
2024-02-16 2024-01-05 4/A ATHA Athira Pharma, Inc.
Common Stock
S - Sale -4,820 144,397 -3.23 2.91 -14,026 420,195
2024-02-16 2024-01-04 4/A ATHA Athira Pharma, Inc.
Common Stock
A - Award 20,000 149,217 15.48
2024-01-08 2024-01-05 4 ATHA Athira Pharma, Inc.
Common Stock
S - Sale -4,820 144,397 -3.23 2.91 -14,026 420,195
2024-01-08 2024-01-04 4 ATHA Athira Pharma, Inc.
Common Stock
A - Award 20,000 149,217 15.48
2023-01-31 2022-11-18 4 ATHA Athira Pharma, Inc.
Common Stock
A - Award 662 129,217 0.51 2.74 1,814 354,055
2022-06-24 2022-06-23 4 ATHA Athira Pharma, Inc.
Common Stock
S - Sale -7,960 128,555 -5.83 2.69 -21,412 345,813
2022-06-24 2022-06-22 4 ATHA Athira Pharma, Inc.
Common Stock
A - Award 20,000 136,515 17.17
2022-06-24 2022-05-18 4 ATHA Athira Pharma, Inc.
Common Stock
A - Award 757 116,515 0.65 7.06 5,344 822,596
2022-01-31 2022-01-27 4 ATHA Athira Pharma, Inc.
Stock Option (Right to Buy)
A - Award 400,000 400,000
2022-01-31 2021-11-18 4 ATHA Athira Pharma, Inc.
Common Stock
A - Award 885 115,758 0.77 12.51 11,071 1,448,133
2021-08-19 2021-08-17 4 ATHA Athira Pharma, Inc.
Stock Option (Right to Buy)
M - Exercise -50,440 100,880 -33.33
2021-08-19 2021-08-17 4 ATHA Athira Pharma, Inc.
Common Stock
M - Exercise 50,440 114,873 78.28 1.35 68,094 155,079
2021-08-19 2021-05-18 4 ATHA Athira Pharma, Inc.
Common Stock
A - Award 867 64,433 1.36 14.45 12,528 931,057
2021-02-22 2021-02-18 4 ATHA Athira Pharma, Inc.
Stock Option (Right to Buy)
A - Award 85,000 85,000
2020-09-22 2020-09-22 4 ATHA Athira Pharma, Inc.
Series B-1 Preferred Stock
C - Conversion -6,563 0 -100.00
2020-09-22 2020-09-22 4 ATHA Athira Pharma, Inc.
Series B-1 Preferred Stock
C - Conversion -6,563 0 -100.00
2020-09-22 2020-09-22 4 ATHA Athira Pharma, Inc.
Series B-1 Preferred Stock
C - Conversion -6,563 0 -100.00
2020-09-22 2020-09-22 4 ATHA Athira Pharma, Inc.
Series B Preferred Stock
C - Conversion -13,126 0 -100.00
2020-09-22 2020-09-22 4 ATHA Athira Pharma, Inc.
Common Stock
C - Conversion 6,563 6,563
2020-09-22 2020-09-22 4 ATHA Athira Pharma, Inc.
Common Stock
C - Conversion 6,563 6,563
2020-09-22 2020-09-22 4 ATHA Athira Pharma, Inc.
Common Stock
C - Conversion 6,563 6,563
2020-09-22 2020-09-22 4 ATHA Athira Pharma, Inc.
Common Stock
C - Conversion 13,126 63,566 26.02
2020-09-17 3 ATHA Athira Pharma, Inc.
Common Stock
50,440
2019-02-08 2019-02-06 4 ALPN ALPINE IMMUNE SCIENCES, INC.
Stock Option (right to buy)
A - Award 75,000 75,000
2019-02-08 2019-02-06 4 ALPN ALPINE IMMUNE SCIENCES, INC.
Stock Option (right to buy)
A - Award 25,000 25,000
2018-08-08 2018-08-06 4 ALPN ALPINE IMMUNE SCIENCES, INC.
Stock Option (right to buy)
A - Award 150,000 150,000
2018-06-05 2018-06-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -22,727 0 -100.00
2018-06-05 2018-06-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -4,474 102,189 -4.19 18.24 -81,587 1,863,498
2018-06-05 2018-06-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -18,253 106,663 -14.61 17.74 -323,825 1,892,298
2018-06-05 2018-06-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 22,727 124,916 22.24 0.99 22,500 123,667
2018-02-21 2018-02-16 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 75,000 75,000
2017-11-15 2017-11-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -16,519 0 -100.00
2017-11-15 2017-11-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -16,519 99,932 -14.19 10.80 -178,486 1,079,755
2017-11-15 2017-11-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 16,519 116,451 16.53 1.65 27,256 192,144
2017-10-18 2017-10-16 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -16,520 16,519 -50.00
2017-10-18 2017-10-16 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -16,520 99,932 -14.19 12.33 -203,703 1,232,232
2017-10-18 2017-10-16 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 16,520 116,452 16.53 1.65 27,258 192,146
2017-01-31 2017-01-27 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 60,000 60,000
2017-01-20 2017-01-18 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -1,498 33,039 -4.34
2017-01-20 2017-01-18 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -1,498 99,932 -1.48 23.10 -34,599 2,308,089
2017-01-20 2017-01-18 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 1,498 101,430 1.50 1.65 2,472 167,360
2017-01-09 2017-01-09 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -500 34,537 -1.43
2017-01-09 2017-01-09 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -500 99,932 -0.50 23.00 -11,500 2,298,436
2017-01-09 2017-01-09 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X -500 100,432 -0.50 1.65 -825 165,713
2017-01-09 2017-01-06 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -1,326 35,037 -3.65
2017-01-09 2017-01-06 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -5,474 0 -100.00
2017-01-09 2017-01-06 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -6,800 99,932 -6.37 23.02 -156,520 2,300,195
2017-01-09 2017-01-06 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 1,326 106,732 1.26 1.65 2,188 176,108
2017-01-09 2017-01-06 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 5,474 105,406 5.48 1.26 6,925 133,339
2017-01-09 2017-01-05 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -2,216 5,474 -28.82
2017-01-09 2017-01-05 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -2,216 99,932 -2.17 23.00 -50,972 2,298,626
2017-01-09 2017-01-05 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 2,216 102,148 2.22 1.26 2,803 129,217
2016-10-19 2016-10-17 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -2,000 26,000 -7.14 27.50 -55,000 715,000
2016-10-19 2016-10-17 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -2,000 26,000 -7.14 27.50 -55,005 715,065
2016-10-19 2016-10-17 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -2,000 26,000 -7.14 27.50 -54,993 714,906
2016-07-14 2016-07-12 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise 25,000 0 -100.00
2016-07-14 2016-07-12 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise 25,000 99,567 33.53 0.38 9,625 38,333
2016-06-15 2016-06-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -200 28,000 -0.71 29.64 -5,928 829,920
2016-06-15 2016-06-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -1,800 28,200 -6.00 28.90 -52,012 814,862
2016-06-15 2016-06-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -100 28,000 -0.36 29.60 -2,960 828,800
2016-06-15 2016-06-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -100 28,000 -0.36 29.60 -2,960 828,800
2016-06-15 2016-06-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -1,900 28,100 -6.33 28.89 -54,900 811,944
2016-06-15 2016-06-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -1,900 28,100 -6.33 28.90 -54,903 811,986
2016-06-01 2016-05-31 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -19,720 25,000 -44.10
2016-06-01 2016-05-31 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -19,720 74,567 -20.91 30.05 -592,566 2,240,664
2016-06-01 2016-05-31 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 19,720 94,287 26.45 0.38 7,592 36,300
2016-06-01 2016-05-27 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -5,280 44,720 -10.56
2016-06-01 2016-05-27 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -5,280 74,567 -6.61 30.06 -158,693 2,241,148
2016-06-01 2016-05-27 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 5,280 79,847 7.08 0.38 2,033 30,741
2016-02-02 2016-01-29 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 50,000 50,000
2016-01-06 2016-01-04 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -25,000 50,000 -33.33
2016-01-06 2016-01-04 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -7,709 73,718 -9.47 31.86 -245,573 2,348,309
2016-01-06 2016-01-04 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -17,291 81,427 -17.52 31.19 -539,379 2,540,050
2016-01-06 2016-01-04 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise X 25,000 98,718 33.91 0.38 9,625 38,006
2015-10-05 2015-10-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -560 72,919 -0.76 32.81 -18,373 2,392,341
2015-10-05 2015-10-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -6,940 73,479 -8.63 32.22 -223,630 2,367,736
2015-09-28 2015-09-24 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -12,764 7,690 -62.40
2015-09-28 2015-09-24 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise 12,764 80,419 18.87 1.26 16,146 101,730
2015-07-06 2015-07-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -7,500 67,655 -9.98 51.10 -383,219 3,456,893
2015-06-08 2015-06-04 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -25,000 75,000 -25.00
2015-06-08 2015-06-04 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale -25,000 75,155 -24.96 44.27 -1,106,852 3,327,420
2015-06-08 2015-06-04 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
M - Exercise 25,000 100,155 33.26 0.38 9,625 38,560
2015-04-03 2015-04-01 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -7,500 74,359 -9.16 27.41 -205,552 2,037,957
2015-01-28 2015-01-27 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -2,300 81,859 -2.73 28.52 -65,602 2,334,840
2015-01-28 2015-01-26 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 35,000 35,000
2015-01-28 2015-01-26 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -5,200 84,159 -5.82 28.03 -145,732 2,358,590
2014-11-24 2014-11-20 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale -30,000 88,484 -25.32 15.63 -469,011 1,383,332
2014-07-10 2014-07-08 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 25,000 25,000
2014-06-30 3/A ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
118,484
2014-06-30 3/A ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
30,000
2014-06-30 3/A ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
30,000
2014-06-30 3/A ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
30,000
2014-05-09 2014-05-07 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 9,090 9,090
2014-05-07 3 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
416,968
2014-05-07 3 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
416,968
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券(例如股票期权)
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券(例如期权)
V
内部人士通过Form 4自愿报告的一笔交易
J
其他(附有交易描述的脚注)